Abbott Laboratories (ABT) Q4 2012 Earnings Results

Abbott Labs Beats on EPS, Stock Down 0.27%

Abbott Labs reported an earnings per share that beat expectations, but the stock still fell slightly by 0.27%. This decline may reflect investor concerns about the lack of revenue data and forward guidance. The cautious tone from management suggests they are aware of market challenges, which could impact future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.51	N/A	+0.80%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding future growth. They emphasized the importance of innovation and market adaptation.

Management highlighted strong performance in key product segments.

They acknowledged challenges in the market but expressed confidence in long-term growth.

Abbott Labs Beats on EPS, Stock Down 0.27%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Labs Beats on EPS, Stock Down 0.27%

Key numbers

Management commentary